(Q42023014)

15 October 2017

Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis (English)

1 reference

15 October 2017

1

1 reference

15 October 2017

Valkonen H

2

1 reference

15 October 2017

Lehtonen L

series ordinal

3

1 reference

15 October 2017

Vainionpää R

series ordinal

4

1 reference

15 October 2017

Ruuskanen O

series ordinal

5

1 reference

15 October 2017

1 January 2005

1 reference

Archives of Disease in Childhood. Fetal and Neonatal Edition

15 October 2017

1 reference

15 October 2017

90

1 reference

15 October 2017

1

1 reference

15 October 2017

F64-8

1 reference

Economic analyses of respiratory syncytial virus immunoprophylaxis in high-risk infants: a systematic review

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1721807

Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1721807

Preventing respiratory syncitial virus bronchiolitis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1721807

Hospitalisation for RSV infection in ex-preterm infants-implications for use of RSV immune globulin

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1721807

Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1721807

Rehospitalization for respiratory syncytial virus among premature infants.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1721807

Respiratory syncytial virus infection

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1721807

Prevention strategies for respiratory syncytial virus: passive and active immunization.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1721807

Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1721807

Respiratory syncytial virus

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1721807

Respiratory syncytial virus infection in children with bronchopulmonary dysplasia

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1721807

Pattern of respiratory syncytial virus epidemics in Finland: two-year cycles with alternating prevalence of groups A and B.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1721807

Shedding of infectious virus and virus antigen during acute infection with respiratory syncytial virus

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1721807

Impact and cost-effectiveness of respiratory syncytial virus prophylaxis for Kansas medicaid's high-risk children

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1721807

Readmission with respiratory syncytial virus (RSV) infection among graduates from a neonatal intensive care unit

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1721807

Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1721807

Respiratory syncytial virus prophylaxis: cost-effective analysis in Argentina

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1721807

Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1721807

Rates of hospitalization for respiratory syncytial virus infection among children in medicaid

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1721807

Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in a United Kingdom cohort

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1721807

Rehospitalization for respiratory illness in infants of less than 32 weeks' gestation

17 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15613580

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comments on palivizumab (Synagis)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15613580

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/ADC.2003.029710

1 reference

15 October 2017

1 reference

15 October 2017

PubMed publication ID

15613580

1 reference